These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
299 related articles for article (PubMed ID: 8712222)
1. The impact of anemia on cardiomyopathy, morbidity, and and mortality in end-stage renal disease. Foley RN; Parfrey PS; Harnett JD; Kent GM; Murray DC; Barre PE Am J Kidney Dis; 1996 Jul; 28(1):53-61. PubMed ID: 8712222 [TBL] [Abstract][Full Text] [Related]
2. Hypoalbuminemia, cardiac morbidity, and mortality in end-stage renal disease. Foley RN; Parfrey PS; Harnett JD; Kent GM; Murray DC; Barre PE J Am Soc Nephrol; 1996 May; 7(5):728-36. PubMed ID: 8738808 [TBL] [Abstract][Full Text] [Related]
3. Impact of hypertension on cardiomyopathy, morbidity and mortality in end-stage renal disease. Foley RN; Parfrey PS; Harnett JD; Kent GM; Murray DC; Barre PE Kidney Int; 1996 May; 49(5):1379-85. PubMed ID: 8731103 [TBL] [Abstract][Full Text] [Related]
4. Cardiac function and hematocrit level. Harnett JD; Kent GM; Foley RN; Parfrey PS Am J Kidney Dis; 1995 Apr; 25(4 Suppl 1):S3-7. PubMed ID: 7702071 [TBL] [Abstract][Full Text] [Related]
5. Hypocalcemia, morbidity, and mortality in end-stage renal disease. Foley RN; Parfrey PS; Harnett JD; Kent GM; Hu L; O'Dea R; Murray DC; Barre PE Am J Nephrol; 1996; 16(5):386-93. PubMed ID: 8886175 [TBL] [Abstract][Full Text] [Related]
6. Hemoglobin of 12 g/dl and above is not associated with increased cardiovascular morbidity in children on hemodialysis. Rheault MN; Molony JT; Nevins T; Herzog CA; Chavers BM Kidney Int; 2017 Jan; 91(1):177-182. PubMed ID: 27865440 [TBL] [Abstract][Full Text] [Related]
7. Mode of dialysis therapy and mortality in end-stage renal disease. Foley RN; Parfrey PS; Harnett JD; Kent GM; O'Dea R; Murray DC; Barre PE J Am Soc Nephrol; 1998 Feb; 9(2):267-76. PubMed ID: 9527403 [TBL] [Abstract][Full Text] [Related]
8. Anemia and hypoalbuminemia at initiation of hemodialysis as risk factor for survival of dialysis patients. Anees M; Ibrahim M J Coll Physicians Surg Pak; 2009 Dec; 19(12):776-80. PubMed ID: 20042156 [TBL] [Abstract][Full Text] [Related]
9. Association of Pre-End-Stage Renal Disease Hemoglobin with Early Dialysis Outcomes. Kleine CE; Soohoo M; Ranasinghe ON; Park C; Marroquin MV; Obi Y; Rhee CM; Moradi H; Kovesdy CP; Kalantar-Zadeh K; Streja E Am J Nephrol; 2018; 47(5):333-342. PubMed ID: 29779027 [TBL] [Abstract][Full Text] [Related]
10. A Telemedicine-Based Registration System for the Management of Renal Anemia in Patients on Maintenance Hemodialysis: Multicenter Study. Ni Z; Jin H; Jiang G; Wang N; Peng A; Guo Z; Bai S; Zhou R; Lu J; Wang Y; Li Y; Zhuang S; Yu C; Deng Y; Jin H; Xu X; Zhang J; Zhao J; Yu X; Wang X; Zhang L; Niu J; Liu K; Bao X; Wang Q; Ma J; Hu C; Zang X; Yu Q J Med Internet Res; 2019 May; 21(5):e13168. PubMed ID: 31344676 [TBL] [Abstract][Full Text] [Related]
11. 2008 Japanese Society for Dialysis Therapy: guidelines for renal anemia in chronic kidney disease. Tsubakihara Y; Nishi S; Akiba T; Hirakata H; Iseki K; Kubota M; Kuriyama S; Komatsu Y; Suzuki M; Nakai S; Hattori M; Babazono T; Hiramatsu M; Yamamoto H; Bessho M; Akizawa T Ther Apher Dial; 2010 Jun; 14(3):240-75. PubMed ID: 20609178 [TBL] [Abstract][Full Text] [Related]
12. Anemia in pediatric dialysis patients in end-stage renal disease network 5. Fadrowski JJ; Furth SL; Fivush BA Pediatr Nephrol; 2004 Sep; 19(9):1029-34. PubMed ID: 15241675 [TBL] [Abstract][Full Text] [Related]
13. The effects of maintenance recombinant human erythropoietin therapy on ambulatory blood pressure recordings: conventional, Doppler, and tissue Doppler echocardiographic parameters. Kirkpantur A; Kahraman S; Yilmaz R; Arici M; Altun B; Erdem Y; Yasavul U; Turgan C Artif Organs; 2005 Dec; 29(12):965-72. PubMed ID: 16305652 [TBL] [Abstract][Full Text] [Related]
14. Hemoglobin response and influence on left ventricular hypertrophy after 24-week treatment of a biosimilar epoetin-alfa in hemodialysis patients with anemia. Thanakitcharu P; Siriwiwatanakul N J Med Assoc Thai; 2007 Dec; 90(12):2574-86. PubMed ID: 18386706 [TBL] [Abstract][Full Text] [Related]
15. Outcome and risk factors of ischemic heart disease in chronic uremia. Parfrey PS; Foley RN; Harnett JD; Kent GM; Murray D; Barre PE Kidney Int; 1996 May; 49(5):1428-34. PubMed ID: 8731110 [TBL] [Abstract][Full Text] [Related]
16. Mortality after Renal Allograft Failure and Return to Dialysis. Brar A; Markell M; Stefanov DG; Timpo E; Jindal RM; Nee R; Sumrani N; John D; Tedla F; Salifu MO Am J Nephrol; 2017; 45(2):180-186. PubMed ID: 28110327 [TBL] [Abstract][Full Text] [Related]
17. Effect of facility-level hemoglobin concentration on dialysis patient risk of transfusion. Collins AJ; Monda KL; Molony JT; Li S; Gilbertson DT; Bradbury BD Am J Kidney Dis; 2014 Jun; 63(6):997-1006. PubMed ID: 24315770 [TBL] [Abstract][Full Text] [Related]
18. Survival advantage of hemodialysis relative to peritoneal dialysis in patients with end-stage renal disease and congestive heart failure. Sens F; Schott-Pethelaz AM; Labeeuw M; Colin C; Villar E Kidney Int; 2011 Nov; 80(9):970-977. PubMed ID: 21775972 [TBL] [Abstract][Full Text] [Related]